Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
14.22
+0.07 (0.49%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $867.2 million as of June 18, 2026. Its market cap has decreased by -41.68% in one year.
Market Cap
867.20M
Enterprise Value
-67.62M
1-Year Change
-41.68%
Ranking
Category
Stock Price
$14.22
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $867.20M, an increase of 41.30%. That is a compound annual growth rate of 7.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 867.20M | 4.48% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Odyssey Therapeutics | 899.61M |
| Arbutus Biopharma | 898.80M |
| Lexicon Pharmaceuticals | 892.83M |
| Alpha Tau Medical | 881.92M |
| Kura Oncology | 881.53M |
| ORIC Pharmaceuticals | 878.86M |
| Phathom Pharmaceuticals | 864.20M |
| LB Pharmaceuticals | 860.30M |